An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA introduces a new food label.
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National Center for Health Research, which analyzes and explains health research to the public. As a result, the new guidance “seems more favorable to the drug companies.”
Packaged foods may soon have warning labels about how much sodium, saturated fats, and added sugars they contain in an effort to curb the chronic disease epidemic, which in large part is due to diet.
CEO Dave Ricks said Monday that the company's GLP-1 weight-loss pill orforglipron could receive FDA approval as soon as early 2026. In an interview with Bloomberg TV, Ricks said the company is expecting data on the drug before the middle of 2025,
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday.
In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of their investigational obesity candidates.
Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on Clinical Obesity says in a new paper in The Lancet Diabetes & Endocrinology. Photo by Towfiqu barbhuiya/ Pexels The way obesity is diagnosed needs to become more sophisticated, an international commission has concluded.
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Biden leaving 11th-hour health measures for TrumpThe Biden administration in its final days has been
Nutrition labels on your favorite grocery items may soon sport a new look. The Food and Drug Administration announced a new proposal Tuesday that would require food and drink manufacturers to place nutrition labels on the front of their products instead of the back.
Sen. Bernie Sanders (I-VT) proposed in February 2024 that the FDA place warning labels about the risk of developing Type 2 diabetes or obesity on foods with high saturated fat, added sugar ...
BMI has long been falling out of favor. When the American Medical Association urged downgrading BMI in 2023, it blamed its “racist exclusion” and “historical harm.” The group also recommended measuring waist circumference as well as body composition.